FIRM FIXED PRICE

TEVA PHARMACEUTICALS USA, INC. - 8511784064!ADENOVIRUS TYPE 4 A

PIID: SPE2DP26F0980
Signed Date: Dec 1, 2025Effective Date: Dec 1, 2025End Date: Closed on Dec 9, 2025
Award $
$1.3M
Vendor
TEVA PHARMACEUTICALS USA, INC.
NAICS
325412
Signed Date
Dec 1, 2025

Key Details

Dollars Obligated
$1.3M
Base & All Options
$1.3M
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Logistics Agency
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
NOT COMPETED
Place of Performance
PARSIPPANY, NJ, 070541120, CD-NJ-11

Description

8511784064!ADENOVIRUS TYPE 4 A

Context & Analysis

On Dec 1, 2025, Department of Defense obligated $1,321,255.44 to TEVA PHARMACEUTICALS USA, INC. for 8511784064!adenovirus type 4 a. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed. Performance is located in PARSIPPANY, NJ.

Contractor Information

UEI: NEN9A34LRHJ5
CAGE Code: 3V8D7
Location: NORTH WALES, PA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related